Research peptides · For laboratory and scientific research in vitro · Not medications · Not approved for consumption · Adults only (18+)
Mazdutide (GLP-1/glucagon dual)
In plain language
Chinese /glucagon dual agonist from Innovent Biologics, licensed from Eli Lilly. Approved in China (June 2025) for body weight management.
For researchers
Dual agonism of and glucagon receptors similar to Survodutide. In Phase 3 GLORY-1 trial showed −15% body weight at 9 mg dose over 48 weeks.
Scientific literature
Information about Mazdutide is based on published scientific research and is intended for research purposes. Not medical advice.
Products related to this peptide are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
5-Amino-1MQ
5-Amino-1MQ
5-Amino-1MQ is a new metabolic peptide studied for improved energy metabolism.
ReadAdipotide
Adipotide (FTPP)
Fat-Targeting Pro-apoptotic Peptide from MD Anderson. Selectively destroys white adipose tissue endothelium via prohibitin receptor binding.
ReadAOD-9604
AOD-9604
AOD-9604 is a growth hormone fragment focused entirely on fat metabolism — without hyperglycemia and without affecting IGF-1.
ReadARA-290
ARA-290 (Cibinetide)
ARA-290 is an innovative peptide for nerve regeneration and neuropathic pain reduction.
ReadArgireline
Argireline (Acetyl Hexapeptide-8)
Synthetic hexapeptide mimicking N-terminus of SNAP-25. Botox-mimetic effect — reduces expression wrinkles by blocking acetylcholine release.
ReadBPC-157
Body Protection Compound 157
BPC-157 is among the most researched peptides for regeneration. Accelerates recovery of tendons, joints and GI tissue.
Read